CA2336703A1
(en)
*
|
1998-07-10 |
2000-01-20 |
The University Of Sydney |
Prophylactic treatments of neovascularisation in macular degeneration
|
CZ20013823A3
(cs)
|
1999-04-26 |
2002-03-13 |
Gmp Vision Solutions, Inc. |
Stentovací zařízení a metoda léčby glaukomu
|
CN1292721C
(zh)
*
|
1999-10-21 |
2007-01-03 |
爱尔康公司 |
药物释放装置
|
US6416777B1
(en)
*
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
US7943162B2
(en)
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
US20050119737A1
(en)
*
|
2000-01-12 |
2005-06-02 |
Bene Eric A. |
Ocular implant and methods for making and using same
|
US6638239B1
(en)
|
2000-04-14 |
2003-10-28 |
Glaukos Corporation |
Apparatus and method for treating glaucoma
|
US20020143284A1
(en)
*
|
2001-04-03 |
2002-10-03 |
Hosheng Tu |
Drug-releasing trabecular implant for glaucoma treatment
|
US7867186B2
(en)
|
2002-04-08 |
2011-01-11 |
Glaukos Corporation |
Devices and methods for treatment of ocular disorders
|
US7708711B2
(en)
|
2000-04-14 |
2010-05-04 |
Glaukos Corporation |
Ocular implant with therapeutic agents and methods thereof
|
AR030345A1
(es)
*
|
2000-08-14 |
2003-08-20 |
Alcon Inc |
Metodo de tratamiento de desordenes relacionados con angiogenesis
|
WO2002056863A2
(en)
*
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
JP4184082B2
(ja)
|
2001-01-03 |
2008-11-19 |
ボシュ・アンド・ロム・インコーポレイテッド |
複数の薬剤を備えた徐放薬剤送達装置
|
JP2004521882A
(ja)
*
|
2001-01-03 |
2004-07-22 |
ボシュ・アンド・ロム・インコーポレイテッド |
組立式透過性プラグを備えた徐放薬剤送達装置
|
JP2004520900A
(ja)
*
|
2001-01-26 |
2004-07-15 |
ボシュ・アンド・ロム・インコーポレイテッド |
徐放薬剤送達装置の改良製造方法
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
CA2683224C
(en)
|
2001-04-07 |
2014-12-02 |
Glaukos Corporation |
System and methods thereof for treatment of ocular disorders
|
US7488303B1
(en)
*
|
2002-09-21 |
2009-02-10 |
Glaukos Corporation |
Ocular implant with anchor and multiple openings
|
US7678065B2
(en)
|
2001-05-02 |
2010-03-16 |
Glaukos Corporation |
Implant with intraocular pressure sensor for glaucoma treatment
|
WO2002089699A2
(en)
|
2001-05-03 |
2002-11-14 |
Glaukos Corporation |
Medical device and methods of use for glaucoma treatment
|
WO2002089767A1
(en)
*
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
EP2316394B1
(en)
|
2001-06-12 |
2016-11-23 |
The Johns Hopkins University |
Reservoir device for intraocular drug delivery
|
CN1203814C
(zh)
*
|
2001-07-23 |
2005-06-01 |
爱尔康公司 |
眼部药物输送装置
|
WO2003009784A1
(en)
*
|
2001-07-23 |
2003-02-06 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
US7331984B2
(en)
|
2001-08-28 |
2008-02-19 |
Glaukos Corporation |
Glaucoma stent for treating glaucoma and methods of use
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
JP2005501602A
(ja)
*
|
2001-08-29 |
2005-01-20 |
カルバーリョ、リカルド エイ.ピー. デ |
治療薬を組織に一方向送達するための封鎖可能な移殖型装置
|
US20060034929A1
(en)
*
|
2001-12-27 |
2006-02-16 |
Brubaker Michael J |
Sustained release drug delivery devices with prefabricated permeable plugs
|
US7186232B1
(en)
|
2002-03-07 |
2007-03-06 |
Glaukoa Corporation |
Fluid infusion methods for glaucoma treatment
|
US7951155B2
(en)
|
2002-03-15 |
2011-05-31 |
Glaukos Corporation |
Combined treatment for cataract and glaucoma treatment
|
US9301875B2
(en)
|
2002-04-08 |
2016-04-05 |
Glaukos Corporation |
Ocular disorder treatment implants with multiple opening
|
EP1534113A4
(en)
*
|
2002-06-12 |
2010-06-09 |
Mann Medical Res Organization |
INJECTION DEVICES AND METHODS FOR IMPLANT TESTING AND TARGETING NON-INTERFERING TARGET LOCATIONS
|
US20070265582A1
(en)
*
|
2002-06-12 |
2007-11-15 |
University Of Southern California |
Injection Devices for Unimpeded Target Location Testing
|
RU2322239C2
(ru)
*
|
2002-08-05 |
2008-04-20 |
Алькон, Инк. |
Применение ацетата анекортава для защиты остроты зрения пациентов с возрастной дегенерацией желтого пятна
|
DE10238310A1
(de)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
Elektrodenanordnung
|
AU2003279055A1
(en)
*
|
2002-09-29 |
2004-04-19 |
Surmodics, Inc. |
Methods for treatment and/or prevention of retinal disease
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
PL378210A1
(pl)
*
|
2003-02-20 |
2006-03-20 |
Alcon, Inc. |
Zastosowanie steroidów do leczenia osób cierpiących z powodu zaburzeń gałki ocznej
|
US20040167109A1
(en)
*
|
2003-02-20 |
2004-08-26 |
Bingaman David P |
Formulations of glucocorticoids to treat pathologic ocular angiogenesis
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
US20040236343A1
(en)
*
|
2003-05-23 |
2004-11-25 |
Taylor Jon B. |
Insertion tool for ocular implant and method for using same
|
KR20060019579A
(ko)
*
|
2003-06-13 |
2006-03-03 |
알콘, 인코퍼레이티드 |
병적 눈 혈관형성을 치료하기 위한 비-스테로이드성항-염증제 제제
|
WO2004112796A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Alcon, Inc. |
Treatment of amd with combination of ingredients
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
CA2522592A1
(en)
*
|
2003-07-10 |
2005-02-03 |
Alcon, Inc. |
Ophthalmic drug delivery device
|
JP4869930B2
(ja)
|
2003-08-26 |
2012-02-08 |
ヴィスタ サイエンティフィック エルエルシー |
眼科薬物供給装置
|
CN102813923B
(zh)
*
|
2003-08-27 |
2015-04-01 |
奥普索特克公司 |
用于治疗眼新血管疾病的组合治疗
|
US7585517B2
(en)
*
|
2003-09-18 |
2009-09-08 |
Macusight, Inc. |
Transscleral delivery
|
US20050158365A1
(en)
*
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
US7276050B2
(en)
*
|
2004-03-02 |
2007-10-02 |
Alan Franklin |
Trans-scleral drug delivery method and apparatus
|
WO2005105133A2
(en)
*
|
2004-04-23 |
2005-11-10 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
US9498457B2
(en)
|
2004-04-30 |
2016-11-22 |
Allergan, Inc. |
Hypotensive prostamide-containing biodegradable intraocular implants and related implants
|
US8673341B2
(en)
*
|
2004-04-30 |
2014-03-18 |
Allergan, Inc. |
Intraocular pressure reduction with intracameral bimatoprost implants
|
US8722097B2
(en)
*
|
2004-04-30 |
2014-05-13 |
Allergan, Inc. |
Oil-in-water method for making polymeric implants containing a hypotensive lipid
|
US20060182781A1
(en)
*
|
2004-04-30 |
2006-08-17 |
Allergan, Inc. |
Methods for treating ocular conditions with cyclic lipid contraining microparticles
|
US7589057B2
(en)
|
2004-04-30 |
2009-09-15 |
Allergan, Inc. |
Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
US7799336B2
(en)
|
2004-04-30 |
2010-09-21 |
Allergan, Inc. |
Hypotensive lipid-containing biodegradable intraocular implants and related methods
|
US7993634B2
(en)
|
2004-04-30 |
2011-08-09 |
Allergan, Inc. |
Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods
|
US20060024350A1
(en)
*
|
2004-06-24 |
2006-02-02 |
Varner Signe E |
Biodegradable ocular devices, methods and systems
|
WO2006014484A2
(en)
*
|
2004-07-02 |
2006-02-09 |
Surmodics, Inc. |
Methods and devices for the treatment of ocular conditions
|
US20060067980A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
DK1848431T3
(da)
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
Flydende formuleringer til behandling af sygdomme eller tilstande
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
JP2008535847A
(ja)
*
|
2005-04-08 |
2008-09-04 |
サーモディクス,インコーポレイティド |
網膜下に送達するための持続放出インプラント
|
EP2446887A3
(en)
*
|
2005-07-12 |
2012-08-15 |
DMI Biosciences, Inc. |
Use of danazol for the treatment of Alzheimer's disease
|
US20070100199A1
(en)
*
|
2005-11-03 |
2007-05-03 |
Lilip Lau |
Apparatus and method of delivering biomaterial to the heart
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
US20070134244A1
(en)
*
|
2005-10-14 |
2007-06-14 |
Alcon, Inc. |
Combination treatment for pathologic ocular angiogenesis
|
JP5528708B2
(ja)
|
2006-02-09 |
2014-06-25 |
参天製薬株式会社 |
安定な製剤ならびにそれらを調製および使用する方法
|
CN101443004B
(zh)
|
2006-03-23 |
2013-03-06 |
参天制药株式会社 |
用于与血管通透性有关的疾病或病症的制剂
|
CN103393483B
(zh)
*
|
2006-03-31 |
2016-08-24 |
玛提治疗有限公司 |
用于鼻泪系统的药物释放方法、结构及组合物
|
US20070293807A1
(en)
*
|
2006-05-01 |
2007-12-20 |
Lynch Mary G |
Dual drainage pathway shunt device and method for treating glaucoma
|
CN101484088A
(zh)
*
|
2006-05-04 |
2009-07-15 |
赫伯特·考夫曼 |
眼治疗剂的给药方法、装置和系统
|
US7981096B2
(en)
*
|
2006-05-12 |
2011-07-19 |
David Castillejos |
Optic nerve head implant and medication delivery system
|
CN101505696B
(zh)
*
|
2006-06-21 |
2012-11-14 |
庄臣及庄臣视力保护公司 |
用于递送活性试剂的泪点塞
|
US8308701B2
(en)
|
2010-11-15 |
2012-11-13 |
Aquesys, Inc. |
Methods for deploying intraocular shunts
|
US10085884B2
(en)
|
2006-06-30 |
2018-10-02 |
Aquesys, Inc. |
Intraocular devices
|
US8663303B2
(en)
|
2010-11-15 |
2014-03-04 |
Aquesys, Inc. |
Methods for deploying an intraocular shunt from a deployment device and into an eye
|
US8721702B2
(en)
|
2010-11-15 |
2014-05-13 |
Aquesys, Inc. |
Intraocular shunt deployment devices
|
US20120123316A1
(en)
|
2010-11-15 |
2012-05-17 |
Aquesys, Inc. |
Intraocular shunts for placement in the intra-tenon's space
|
US8852256B2
(en)
|
2010-11-15 |
2014-10-07 |
Aquesys, Inc. |
Methods for intraocular shunt placement
|
WO2008005873A2
(en)
|
2006-06-30 |
2008-01-10 |
Aquesys Inc. |
Methods, systems and apparatus for relieving pressure in an organ
|
EP2088976B1
(en)
|
2006-11-10 |
2019-07-03 |
Glaukos Corporation |
Uveoscleral shunt
|
US20100034808A1
(en)
*
|
2006-11-21 |
2010-02-11 |
Toru Nakazawa |
Compositions and methods for preserving cells of the eye
|
WO2008073576A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Alcon, Inc. |
Drug delivery device
|
JP5323720B2
(ja)
*
|
2006-12-18 |
2013-10-23 |
アルコン リサーチ, リミテッド |
眼用薬物送達のためのデバイスおよび方法
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
CN102176931B
(zh)
*
|
2008-08-09 |
2015-03-04 |
麻省理工学院 |
治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
|
US20100104654A1
(en)
*
|
2008-10-27 |
2010-04-29 |
Allergan, Inc. |
Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
WO2010088548A1
(en)
|
2009-01-29 |
2010-08-05 |
Forsight Labs, Llc |
Posterior segment drug delivery
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
WO2010141729A1
(en)
|
2009-06-03 |
2010-12-09 |
Forsight Labs, Llc |
Anterior segment drug delivery
|
PL2554171T3
(pl)
|
2009-06-22 |
2015-03-31 |
Ampio Pharmaceuticals Inc |
Sposób leczenia chorób
|
SG177302A1
(en)
*
|
2009-06-22 |
2012-02-28 |
Dmi Acquisition Corp |
Methods and products for treatment of diseases
|
US8529492B2
(en)
|
2009-12-23 |
2013-09-10 |
Trascend Medical, Inc. |
Drug delivery devices and methods
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
EP2555749B1
(en)
*
|
2010-04-06 |
2016-10-26 |
Allergan, Inc. |
Sustained-release reservoir implants for intracameral drug delivery
|
AU2011242465B2
(en)
|
2010-04-23 |
2017-01-19 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for preserving photoreceptor and retinal pigment epithelial cells
|
CA2798084A1
(en)
|
2010-05-17 |
2011-11-24 |
Aerie Pharmaceuticals, Inc. |
Drug delivery devices for delivery of ocular therapeutic agents
|
CN105435338B
(zh)
|
2010-08-05 |
2019-03-26 |
弗赛特影像4股份有限公司 |
用于药物输送的注入器装置和方法
|
WO2012019139A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
PL2600812T3
(pl)
|
2010-08-05 |
2022-01-24 |
Forsight Vision4, Inc. |
Urządzenie do leczenia oczu
|
US20120109054A1
(en)
*
|
2010-10-29 |
2012-05-03 |
Vista Scientific Llc |
Devices with an erodible surface for delivering at least one active agent to tissue over a prolonged period of time
|
US20140024598A1
(en)
|
2010-11-01 |
2014-01-23 |
Demetrios Vavvas |
Methods and compositions for preserving retinal ganglion cells
|
US20160256317A1
(en)
|
2010-11-15 |
2016-09-08 |
Aquesys, Inc. |
Methods for implanting intraocular shunts
|
US20140031769A1
(en)
|
2010-11-19 |
2014-01-30 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
CA2825399A1
(en)
*
|
2011-02-04 |
2012-08-09 |
Taris Biomedical, Inc. |
Implantable device for controlled release of low solubility drug
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
WO2013003467A2
(en)
|
2011-06-27 |
2013-01-03 |
Massachusetts Eye And Ear Infirmary |
Methods for treating ocular inflammatory disorders
|
EP4249059A3
(en)
|
2011-06-28 |
2023-11-29 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
WO2013025840A1
(en)
|
2011-08-15 |
2013-02-21 |
Massachusetts Eye And Ear Infirmary |
Methods for preserving photoreceptor cell viability following retinal detachment
|
US9102105B2
(en)
*
|
2011-09-13 |
2015-08-11 |
Vista Scientific Llc |
Method for forming an ocular drug delivery device
|
WO2013040079A1
(en)
|
2011-09-13 |
2013-03-21 |
Dose Medical Corporation |
Intraocular physiological sensor
|
CN106073986B
(zh)
|
2011-09-14 |
2019-01-11 |
弗赛特影像5股份有限公司 |
治疗患者的眼睛的装置
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
CA2888805C
(en)
|
2011-10-21 |
2020-07-14 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for promoting axon regeneration and nerve function
|
US9610195B2
(en)
|
2013-02-27 |
2017-04-04 |
Aquesys, Inc. |
Intraocular shunt implantation methods and devices
|
US8852136B2
(en)
*
|
2011-12-08 |
2014-10-07 |
Aquesys, Inc. |
Methods for placing a shunt into the intra-scleral space
|
US9808373B2
(en)
|
2013-06-28 |
2017-11-07 |
Aquesys, Inc. |
Intraocular shunt implantation
|
US8765210B2
(en)
|
2011-12-08 |
2014-07-01 |
Aquesys, Inc. |
Systems and methods for making gelatin shunts
|
US10080682B2
(en)
|
2011-12-08 |
2018-09-25 |
Aquesys, Inc. |
Intrascleral shunt placement
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
EP2708209A1
(en)
*
|
2012-09-13 |
2014-03-19 |
AJL Ophthalmic, S.A. |
Scleral epimacular implant
|
WO2014066775A1
(en)
|
2012-10-26 |
2014-05-01 |
Forsight Vision5, Inc. |
Ophthalmic system for sustained release of drug to eye
|
US10064717B2
(en)
*
|
2012-11-01 |
2018-09-04 |
Poway Retinal Technologies, Llc |
Retinal repair device and method
|
SG10201705044YA
(en)
|
2012-12-19 |
2017-07-28 |
Ampio Pharmaceuticals Inc |
Method for treatment of diseases
|
DK2956476T3
(da)
|
2013-02-18 |
2020-02-17 |
Vegenics Pty Ltd |
Ligandbindende molekyler og anvendelser deraf
|
US10159600B2
(en)
|
2013-02-19 |
2018-12-25 |
Aquesys, Inc. |
Adjustable intraocular flow regulation
|
TW201507749A
(zh)
|
2013-03-11 |
2015-03-01 |
Sanofi Aventis Deutschland |
用於藥物輸送裝置之組件
|
US9730638B2
(en)
|
2013-03-13 |
2017-08-15 |
Glaukos Corporation |
Intraocular physiological sensor
|
EP2968113B8
(en)
|
2013-03-14 |
2020-10-28 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
US9592151B2
(en)
|
2013-03-15 |
2017-03-14 |
Glaukos Corporation |
Systems and methods for delivering an ocular implant to the suprachoroidal space within an eye
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
US10098836B2
(en)
|
2013-05-02 |
2018-10-16 |
Retina Foundation Of The Southwest |
Method for forming a molded two-layer ocular implant
|
KR20220061248A
(ko)
|
2013-07-12 |
2022-05-12 |
이베릭 바이오, 인크. |
안과적 질환을 치료하거나 예방하기 위한 방법
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
EP3068354B1
(en)
|
2013-11-14 |
2023-06-28 |
Aquesys, Inc. |
Intraocular shunt inserter
|
EP3089748A4
(en)
|
2014-01-02 |
2017-09-27 |
Massachusetts Eye & Ear Infirmary |
Treating ocular neovascularization
|
US11028388B2
(en)
|
2014-03-05 |
2021-06-08 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for treating Usher syndrome and retinitis pigmentosa
|
US11141493B2
(en)
|
2014-03-10 |
2021-10-12 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
US11339437B2
(en)
|
2014-03-10 |
2022-05-24 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290-associated disease
|
ES2745769T3
(es)
|
2014-03-10 |
2020-03-03 |
Editas Medicine Inc |
Procedimientos y composiciones relacionados con CRISPR/CAS para tratar la amaurosis congénita de Leber 10 (LCA10)
|
WO2015148863A2
(en)
|
2014-03-26 |
2015-10-01 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating sickle cell disease
|
EP3148491B1
(en)
|
2014-05-29 |
2020-07-01 |
Glaukos Corporation |
Implants with controlled drug delivery features and manufacturing method for said implants
|
MY182497A
(en)
|
2014-07-15 |
2021-01-25 |
Forsight Vision4 Inc |
Ocular implant delivery device and method
|
BR112017002466A2
(pt)
|
2014-08-08 |
2017-12-05 |
Forsight Vision4 Inc |
formulações estáveis e solúveis de inibidores da tirosina cinase do receptor, e métodos para a sua preparação
|
SG11201703726XA
(en)
|
2014-11-10 |
2017-06-29 |
Forsight Vision4 Inc |
Expandable drug delivery devices and method of use
|
WO2016168141A1
(en)
|
2015-04-13 |
2016-10-20 |
Forsight Vision5, Inc. |
Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
|
EP4019975A1
(en)
|
2015-04-24 |
2022-06-29 |
Editas Medicine, Inc. |
Evaluation of cas9 molecule/guide rna molecule complexes
|
US10010502B2
(en)
|
2015-05-19 |
2018-07-03 |
Amorphex Therapeutics Llc |
Device that delivers a sustained low-dose of a myopia-suppressing drug, while preserving pupillary function and accommodation
|
UA122570C2
(uk)
|
2015-06-03 |
2020-12-10 |
Аквісіс, Інк. |
Розміщення ab externo внутрішньоочного шунта
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
WO2017075475A1
(en)
|
2015-10-30 |
2017-05-04 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
KR20180084104A
(ko)
|
2015-11-20 |
2018-07-24 |
포사이트 비젼4, 인크. |
연장 방출 약물 전달 장치를 위한 다공성 구조물
|
WO2017165862A1
(en)
|
2016-03-25 |
2017-09-28 |
Editas Medicine, Inc. |
Systems and methods for treating alpha 1-antitrypsin (a1at) deficiency
|
JP7009384B2
(ja)
|
2016-04-05 |
2022-01-25 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
移植可能な眼薬送達デバイス
|
CA3022830A1
(en)
|
2016-04-20 |
2017-10-26 |
Harold Alexander Heitzmann |
Bioresorbable ocular drug delivery device
|
CA3025526A1
(en)
|
2016-06-02 |
2017-12-07 |
Aquesys, Inc. |
Intraocular drug delivery
|
US11566263B2
(en)
|
2016-08-02 |
2023-01-31 |
Editas Medicine, Inc. |
Compositions and methods for treating CEP290 associated disease
|
US11040019B2
(en)
|
2016-08-19 |
2021-06-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration
|
EP3532616A1
(en)
|
2016-10-28 |
2019-09-04 |
Editas Medicine, Inc. |
Crispr/cas-related methods and compositions for treating herpes simplex virus
|
JP2020514407A
(ja)
|
2017-01-24 |
2020-05-21 |
マクリーゲン, インク.Macregen, Inc. |
アポリポプロテイン模倣物を用いる加齢黄斑変性と他の眼疾患の治療
|
CA3054497A1
(en)
|
2017-03-03 |
2018-09-07 |
Macregen, Inc. |
Treatment of age-related macular degeneration and other eye diseases with one or more therapeutic agents
|
EP3596217A1
(en)
|
2017-03-14 |
2020-01-22 |
Editas Medicine, Inc. |
Systems and methods for the treatment of hemoglobinopathies
|
KR20190141775A
(ko)
|
2017-05-05 |
2019-12-24 |
유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
기질 결합 소낭의 안구에의 적용
|
EP3622070A2
(en)
|
2017-05-10 |
2020-03-18 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease systems and methods
|
EP3654941A1
(en)
|
2017-07-17 |
2020-05-27 |
Keith Roizman |
Topical delivery of therapeutic agents comprising cell-penetrating peptides for use for the treatment of age-related macular degeneration and other eye diseases
|
US11246753B2
(en)
|
2017-11-08 |
2022-02-15 |
Aquesys, Inc. |
Manually adjustable intraocular flow regulation
|
WO2019103906A1
(en)
|
2017-11-21 |
2019-05-31 |
Forsight Vision4, Inc. |
Fluid exchange apparatus for expandable port delivery system and methods of use
|
EP3758736B1
(en)
|
2018-03-02 |
2024-05-01 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Il-34 for use in a method of treating retinal inflammation and neurodegeneration
|
US10952898B2
(en)
|
2018-03-09 |
2021-03-23 |
Aquesys, Inc. |
Intraocular shunt inserter
|
US11135089B2
(en)
|
2018-03-09 |
2021-10-05 |
Aquesys, Inc. |
Intraocular shunt inserter
|
AU2020227740A1
(en)
|
2019-02-25 |
2021-10-07 |
Editas Medicine, Inc. |
CRISPR/RNA-guided nuclease-related methods and compositions for treating RHO-associated autosomal-dominant retinitis pigmentosa (adRP)
|
EP4090381A1
(en)
|
2020-01-17 |
2022-11-23 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
<smallcaps/>? ? ?crx-? ? ? ? ?gene therapy for treatment ofautosomal dominant retinopathies
|
EP4175636A2
(en)
|
2020-07-02 |
2023-05-10 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Cyclic compounds for use in treating retinal degeneration
|
EP4323522A1
(en)
|
2021-04-16 |
2024-02-21 |
Editas Medicine, Inc. |
Crispr/rna-guided nuclease-related methods and compositions for treating rho-associated autosomal-dominant retinitis pigmentosa (adrp)
|
CN115737892A
(zh)
*
|
2022-11-21 |
2023-03-07 |
诺莱生物医学科技有限公司 |
搭载修复基质的弹性敷料及其制备方法
|